|Articles|January 11, 2023
- Pharmaceutical Executive: January 2023
- Volume 43
- Issue 01
Pharmaceutical Executive, January 2023 Issue (PDF)
Click the title above for a link to open the Pharmaceutical Executive January 2023 issue in an interactive PDF format.
Advertisement
Articles in this issue
about 3 years ago
Key Factors Attributing to a Successful Product Launchabout 3 years ago
Closing the Digital Gap: FDA’s Oversight of Social Mediaabout 3 years ago
Sales-Rep Compensation: Adding Long-Term Incentives to Mixabout 3 years ago
Co-creating New Innovationsabout 3 years ago
The Potential Impact of the IRAabout 3 years ago
Patient Hubs Continue Growthabout 3 years ago
Social Media’s Complex Climbabout 3 years ago
Industry Workforce Seeks Clarityabout 3 years ago
Cybersecurity Threats & PharmaNewsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
The Influence of Trump Rx in Pharmacy Benefit Managers, Retail Pharmacies, and Digital Health Platforms
2
Leading in the Psychedelic Space: Q&A with Tarek Rabah
3
Boehringer Ingelheim Acquires Exclusive License from Sitryx Therapeutics for Preclinical Small Molecule Program
4
Pharma Leadership Roundup: Sarepta Therapeutics CEO Announces Retirement, Rivus Pharmaceuticals Appoints New CEO
5